FOLD: 爱美医疗

FOLD新闻

• 21:19 Amicus Therapeutics股东批准BioMarin Pharmaceutical收购交易
• 21:17 Amicus Therapeutics shareholders approve acquisition by BioMarin Pharmaceutical
• 08:00 Stocks With Rising Relative Strength: Vertex Pharmaceuticals
• 08:00 Vertex Gets Rating Upgrade, Earnings Rose Every Quarter This Past Year
• 14:10 Canaccord raises BioMarin stock price target to $104 on earnings
• 08:00 Celldex Therapeutics Stock Earns 88 RS Rating
• 16:35 BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market
• 22:58 BioMarin 2025年第四季度业绩:营收增长17%但ROCTAVIAN计提费用拖累盈利
• 21:36 BioMarin第四季度业绩喜忧参半,股价小幅下跌
• 21:35 BioMarin posts mixed Q4 results, shares edge lower
• 16:30 BioMarin财报即将公布,Voxzogo担忧导致预期下调
• 16:12 Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues
• 15:38 BioMarin earnings loom with estimates falling on Voxzogo worries
• 16:06 Amicus earnings on deck as $4.8B BioMarin deal awaits vote
• 19:11 What to Expect From These Drug/Biotech Players This Earnings Season?
• 15:35 贝尔德维持生物马林股票评级，尽管竞争对手临床试验数据积极
• 15:34 Baird maintains BioMarin stock rating amid competitor’s positive trial data
• 13:30 Should Investors Buy, Sell or Hold Amicus Stock Ahead of Q4 Earnings?
• 13:39 Amicus将在研讨会上展示罕见疾病治疗的新数据
• 13:37 Amicus to present new data on rare disease treatments at symposium
• 05:29 Top 3 Health Care Stocks That May Implode In Q1 - Brookdale Senior Living (NYSE:BKD), Amicus Therapeutics (NASDAQ:FOLD)
• 11:17 The Right Play On BioMarin Pharmaceuticals (NASDAQ:BMRN)
• 16:24 FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?
• 14:19 LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)